Cargando…
The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
Drug resistance, including adriamycin (ADR)-based therapeutic resistance, is a crucial cause of chemotherapy failure in breast cancer treatment. Acquired chemoresistance has been identified to be closely associated with the overexpression of P-glycoprotein (P-gp/ABCB1). Long non-coding RNA (lncRNA)...
Autores principales: | Chen, Zhaolin, Pan, Tingting, Jiang, Duochen, Jin, Le, Geng, Yadi, Feng, Xiaojun, Shen, Aizong, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056627/ https://www.ncbi.nlm.nih.gov/pubmed/32160712 http://dx.doi.org/10.1016/j.omtn.2020.01.030 |
Ejemplares similares
-
LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR‐34a/DKK1/Wnt‐β‐catenin signalling
por: Fang, Qingxia, et al.
Publicado: (2020) -
LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer
por: Ma, Siping, et al.
Publicado: (2018) -
miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer
por: Zong, Yuanyuan, et al.
Publicado: (2019) -
Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway
por: Das, Abhijit, et al.
Publicado: (2023) -
Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
por: Corrêa, Stephany, et al.
Publicado: (2012)